
44 segments available
In this segment, Lex Fridman introduces Regina Barzilay, a prominent MIT professor and researcher specializing in natural language processing and deep learning applications in oncology. The discussion sets the stage for exploring how deep learning can revolutionize cancer diagnosis and treatment.
"the following is a conversation with Regina Bardsley she's a professor at MIT and a world-class researcher in natural language processing and applications of deep learning to chemistry and oncology or..."
Regina shares how literature has profoundly influenced her worldview, particularly mentioning 'The Emperor of All Maladies,' a historical account of cancer treatment development. She reflects on the imperfections of the scientific discovery process and how this book reshaped her understanding of science and its implementation.
"in an interview you've mentioned that if there's one course you would take it would be a literature course for the friend of yours that a friend of your teachers just out of curiosity because I couldn..."
Regina discusses the impact of the novel 'Americana' on her life, highlighting themes of cultural adaptation and identity. She recounts a humorous experience that illustrates the challenges of communication in a new country, emphasizing how literature can mirror personal experiences and broaden one's perspective.
"of a book which is not kind of which is a fiction book is a book called Americana and this is a book about a young female student who comes from Africa to study in the United States and it describes h..."
In this segment, Regina reflects on the importance of personalities in the scientific community, arguing that while ideas are crucial, the dedication of individuals often drives progress. She contrasts historical attitudes in AI research with current trends, emphasizing how influential figures can shape the direction of scientific fields.
"understanding of the world on the on the science question you mentioned that it made you discover that personalities of human beings are more important than perhaps ideas is that what I heard it's not..."
Regina discusses the historical context of cancer treatment development, revealing the complexities and imperfections of the scientific process. She shares insights from 'The Emperor of All Maladies,' illustrating how past mistakes in drug development highlight the need for more effective and rapid advancements in cancer research.
"adds speed up the rate of adoption of the new ideas yeah and and the other interesting question is in the early days of particular discipline I think you mentioned in in that book was is ultimately a ..."
Regina explores the intersection of computer science and biology, questioning the traditional emphasis on mechanistic understanding in medicine. She advocates for a probabilistic approach to understanding complex biological systems, suggesting that this perspective could lead to breakthroughs in early diagnostics and treatment.
"thinking is a computer scientist about this problem I think one of the reasons that we succeeded in the areas we as a computer scientist succeeded is because we don't have we are not trying to underst..."
Regina opens up about her breast cancer diagnosis in 2014 and how it forced her to confront her mortality. She reflects on the emotional turmoil during her diagnosis and how this experience reshaped her priorities in both her personal life and scientific career, prompting her to reevaluate what truly matters.
"stuff that works and but that can be like you said separate from this deep human desire to uncover the mysteries of the universe of of science of the way the body works the way the mind works it's the..."
In this concluding segment, Regina discusses the importance of prioritizing impactful work in science. She reflects on her journey and the realization that many scientific pursuits may seem trivial in the face of real-world suffering, urging a focus on meaningful contributions that can lead to significant change.
"sufferings that I'm kind of totally shouldered on it on daily basis and it's like the first time I've seen like real life and real suffering and I was thinking why are we trying to improve the parser ..."
In this segment, Barzilay describes how her cancer diagnosis opened her eyes to the realities of illness and suffering. She reflects on the stark contrast between her experiences and the carefree attitudes of those who are unaware of their health risks. This moment of realization underscores the urgency for researchers to apply their skills to alleviate suffering and improve cancer treatment.
"of your scientific community and pursue that vision so though that moment did it make you cognizant you mentioned suffering of just the general amount of suffering in the world is that what you're ref..."
Barzilay discusses the potential of machine learning to revolutionize cancer diagnosis and treatment. She highlights the importance of early detection and the advancements in AI that could lead to better outcomes for patients. This segment explores the intersection of technology and healthcare, emphasizing the need for innovative solutions in the fight against cancer.
"they're very different from this other my people and second of singing I think it totally crazy they're like laughing and wasting their money on some stupid gifts and you know they may die they alread..."
In this segment, Barzilay addresses the challenges of cancer detection and the limitations of current statistical models. She emphasizes the need for improved data utilization through machine learning to identify at-risk patients. This discussion highlights the critical role of data in enhancing cancer diagnosis and the potential for AI to transform patient outcomes.
"so this has a huge impact United States global when broadly before we talk about how machine learning how MIT can help when do you think we as a civilization will cure cancer how hard of a problem is ..."
Barzilay elaborates on the significance of early detection in improving cancer survival rates. She shares insights into how advancements in technology can facilitate earlier diagnosis, particularly for aggressive cancers like pancreatic cancer. This segment underscores the urgency of developing effective detection methods to save lives.
"implement it and they think this is a very big piece of puzzle that is currently not addressed the see really interesting question so first a small detail that I think the answer is yes but is cancer ..."
In this segment, Barzilay explains how machine learning can enhance cancer prediction by analyzing vast amounts of data. She discusses the potential for AI to identify susceptibility to various cancers, emphasizing the need for comprehensive data integration. This discussion highlights the transformative power of technology in the realm of cancer research.
"and I just want to say that as I got more into this field I realize that you know countries of course terrible disease but they're really the whole slew of terrible diseases out there like neurodegene..."
Barzilay addresses the significant challenges in accessing cancer-related data for research. She explains the barriers faced by researchers in obtaining modern datasets and the implications for advancing cancer diagnosis. This segment sheds light on the critical need for improved data sharing practices in the medical community.
"and for the vast majority of patients especially on the younger patients it really comes as a surprise like for instance for breast cancer 80% of the patients are first in their families it's like me ..."
In this segment, Barzilay discusses the ethical considerations surrounding patient data privacy in cancer research. She emphasizes the importance of establishing trust and transparency in data sharing to facilitate research advancements. This discussion highlights the balance between privacy concerns and the need for collaborative efforts in the medical field.
"what are the challenges in gathering large data sets in the space again another great question so it took me after I decided that I want to work on it two years to get access to data and like right no..."
Barzilay explores potential solutions for improving data sharing in cancer research. She discusses technical advancements that can enhance data anonymization and the importance of patient consent in research. This segment emphasizes the need for innovative approaches to overcome barriers in data accessibility.
"but if you yourself know I community they don't know that many people culturally ever go to access to data because it's very challenging process and Sarge isn't a quick comment eat MGH or any kind of ..."
In this concluding segment, Barzilay reflects on the future of cancer research and the role of technology in transforming patient care. She emphasizes the collaborative efforts needed across disciplines to tackle cancer effectively. This discussion encapsulates the hope and potential for advancements in cancer diagnosis and treatment through innovative research.
"it would be really a game-changer people when they think about this problem there's a it depends on the population the pains and the demographics but there's some privacy concerns generally we're not ..."
Barzilay shares her experiences with patients seeking statistical insights to make informed decisions about their health. She highlights the emotional weight of these decisions and the critical role that accessible information plays in empowering patients. This segment emphasizes the urgency of providing patients with the data they need to feel secure in their healthcare choices.
"talking about societal benefits and about the education the public needs to understand that I think that there are situation and I still remember myself when I really needed an answer I had to make a ..."
This segment discusses the potential for a more efficient health data exchange system that allows patients to easily transfer their medical records between providers. Barzilay reflects on past attempts by companies like Microsoft and Google to create such systems and the challenges they faced. The conversation highlights the need for regulatory support and innovative solutions to improve patient data mobility.
"you would feel vulnerable and unprotected and then the question is you know what do I care more because at the end everything is a trainer of correct yeah exactly just out of curiosity what it seems l..."
Barzilay addresses the barriers to adopting AI technologies in healthcare, particularly in oncology. She discusses the complexities of regulatory approval and the need for computer scientists to understand the healthcare landscape better. This segment sheds light on the challenges faced by AI researchers in translating their innovations into practical applications that can improve patient care.
"player in this field but I can clearly see that even you know for even for totally selfish health reasons when you are going to a new facility and many of us ascend to some specialized treatment they ..."
In this segment, Barzilay explains the concept of breast density and its significance in cancer risk assessment. She discusses the historical context of density evaluation and its implications for patient care. The segment highlights the need for more accurate predictive models in breast cancer screening and the challenges of integrating new technologies into existing healthcare practices.
"data collection I know that is an initiative in Massachusetts the thing that you led by the governor to try to create this kind of house exchange system or at least to help people who kind of when you..."
Barzilay emphasizes the role of patient advocacy in shaping breast cancer screening practices. She recounts how patient experiences have driven changes in legislation regarding breast density notifications. This segment illustrates the power of informed patients in influencing healthcare policies and improving outcomes for women at risk of breast cancer.
"let me give you example related to my breast cancer research so traditional in traditional breast cancer risk assessment there is something called density which determines the likelihood of a woman to..."
Barzilay discusses the untapped potential of AI in drug design, highlighting the current lack of AI-developed drugs. She emphasizes the importance of using machine learning to generate molecules with desired properties and the need for innovation in this area. This segment points to the future of AI in healthcare, particularly in developing new treatments for cancer.
"that between 40 and 50 percent of women have dense breasts so about 40 percent of patients are coming out of their screening and somebody tells them you are in high risk now what exactly does it mean ..."
In this closing segment, Barzilay reflects on the complexities of the American healthcare system and the challenges faced by newcomers in the field. She discusses the importance of understanding the incentives and barriers within the system to drive meaningful change. This segment serves as a call to action for those in technology and healthcare to collaborate for better patient outcomes.
"you train the machine to look at the image and to say the risk in one to five years now you can ask me how long it will take to substitute this density which is broadly used across the country and I r..."
Regina Barzilay discusses the critical role of consumers in the healthcare system, emphasizing that while there are many stakeholders, the collective voice of patients can drive the adoption of AI in healthcare. She highlights the importance of clear communication about AI's potential in improving care, moving beyond hype to tangible examples that resonate with everyone, including policymakers.
"successful if we push on this group of people is that the doctors is it the hospitals is it the governments of policymakers is it the individual patients consumers who needs to be inspired to most lik..."
Barzilay identifies significant open problems in applying machine learning to oncology, particularly in drug design. She notes that while early detection is crucial, the development of new drugs remains a challenge, with current methods lacking the integration of machine learning. This segment explores the potential for innovation in drug design through advanced ML techniques.
"it sounds like the biggest problems are outside of AI in terms of the biggest impact at this point but are there any open problems in the application of ml to oncology in general so improving the dete..."
In this segment, Barzilay elaborates on the exciting possibilities in drug design using machine learning. She discusses the need for innovative approaches to generate molecules with desired properties and the importance of graph-based methods in this process. The conversation highlights the technical creativity required to advance drug discovery in healthcare.
"honest with you now when we are doing diagnostics and imaging primarily taking the ideas that we develop for other areas and you applying them with some adaptation the area of you know drug design is ..."
Barzilay explains the traditional process of drug discovery, focusing on high-throughput screening and the role of chemists in optimizing drug properties. She emphasizes the importance of domain knowledge in this process and how machine learning can enhance the efficiency and effectiveness of drug design, paving the way for new therapeutic options.
"area and some of these techniques are really unique to let's say to you know graph generation and other things so what just an interpreter quick I'm sorry graph generation or graphs drug discovery in ..."
This segment delves into the intersection of machine learning and chemistry, where Barzilay discusses how ML can revolutionize drug design. She highlights the limitations of traditional methods and the potential for ML to analyze vast datasets of molecular interactions, ultimately leading to more effective drug development strategies.
"done in simulation or just by looking at the molecules or do you need to actually run reactions and real labs with lab it is so when you do high throughput screening you really do screening it's in th..."
Barzilay emphasizes the crucial role of domain experts in drug design, explaining how their deep understanding of chemistry informs the optimization of drug properties. She discusses the collaborative nature of drug development and how machine learning can augment the capabilities of chemists, leading to innovative solutions in healthcare.
"right ones sounds like the the breast density heuristic from sixty seven the same echoes it's unnecessary is that it's really you know it's really driven by deep understand it so like they just observ..."
In this segment, Barzilay shares insights into advancements in predicting molecular properties using machine learning. She discusses the evolution of techniques from simple models to more complex systems that can generate and modify molecules, showcasing the exciting potential for innovation in drug discovery.
"there's a lot of thing that you can do here so we do a lot of work so the first tool that we started with was the tool that can predict properties of the molecules so you can just give the molecular m..."
Barzilay reflects on her journey in natural language processing (NLP) since the late 1990s, discussing the transition from rule-based approaches to data-driven methods. She highlights the impact of deep learning on NLP and the diminishing role of linguistic theories, emphasizing the need for a balance between empirical performance and linguistic understanding.
"so there's a lot of promise speaking of machine translation and embeddings I think you do you have done a lot of really great research in NLP natural language processing can you tell me your journey t..."
In this concluding segment, Barzilay addresses the challenges of achieving true language understanding with deep learning models. She discusses the limitations of current systems and the importance of improving generalization capabilities, raising questions about the future of NLP and the potential for deeper insights into human language.
"know increased performance across many basic tasks the sad part of the story may be that if you look again through this journey we see that the role of linguistics in some ways greatly diminishes and ..."
In this segment, Barzilay explores the potential of deep neural networks in understanding language. She raises questions about the limits of current models and their ability to generalize across different domains. The discussion touches on the complexities of language understanding and the challenges faced by AI in achieving human-like comprehension.
"coming back to a question about biology then you know in linguistics people try to go this way and try to write the the syntactic trees and try to abstract it and to find the right representation and ..."
Barzilay contrasts the performance of machine translation systems with human language processing. She discusses the limitations of current AI models in replicating human understanding and the brittleness of these systems when faced with unfamiliar contexts. This segment emphasizes the ongoing challenges in bridging the gap between machine capabilities and human cognition.
"it's unknown I suppose but as we start to creep towards romantic notions of the spirit of the Turing test and conversation and dialogue and something that may be to to me or to us silly humans feels l..."
The conversation shifts to the Turing Test and the nature of human-machine interaction. Barzilay reflects on the challenges of creating AI that can engage in meaningful conversations. She shares anecdotes about people's willingness to interact with simple AI systems, raising questions about the essence of human connection and the expectations we have of AI.
"translation as we are doing now if you go to cognitive science we still don't really understand what we are doing I mean there are a lot of theories so there is obviously a lot of progress and standin..."
Barzilay discusses the potential for AI to augment human intelligence rather than replace it. She draws parallels between technological advancements and human cognitive abilities, suggesting that AI could enhance our thinking processes. This segment explores the philosophical implications of AI development and its impact on human cognition.
"no big part of their training refers to our so but in terms of outcomes that's a really clean good way to look at it I guess the question I was asking is do you think the imagine of future do you thin..."
In this segment, Barzilay envisions a future where AI technologies enhance human cognitive functions. She discusses the implications of brain-computer interfaces and how they could change our understanding of attention and motivation. This forward-looking discussion highlights the potential for AI to transform human capabilities.
"so I'm not sure how much intelligence we exhibit to each other you know with the people we love that we're close with so it's a very interesting point of what it means to pass the Turing test well lan..."
Barzilay shares personal anecdotes about her experiences with technology and motivation. She reflects on how simple tools can influence attention and productivity, illustrating the broader theme of how AI can impact human behavior. This segment provides a relatable perspective on the intersection of technology and personal growth.
"there are you at all excited curious by the possibility of creating human level intelligence is this is you've been very in your discussion so if we're looking at oncology you're trying to use machine..."
In this segment, Barzilay reflects on her experience teaching machine learning at MIT. She highlights the challenges faced by non-majors in understanding complex concepts and discusses the creation of a new course designed to make machine learning more accessible to a broader audience.
"ways with myself I have my zone up from that I go to MIT gym it kind of records you know how much the Duran and you have points and you could get some status whatever like what is this ridiculous thin..."
Barzilay emphasizes the necessity of programming skills in today's world, suggesting that everyone, regardless of their major, should learn to code. She discusses the barriers non-majors face in her machine learning class and the foundational knowledge that could enhance their learning experience.
"of psychology actually as well as seeing how our behavior has changed with basically all human relations now have other non-human entities helping us out so you uh you teach a large a huge machine lea..."
Barzilay offers guidance for students interested in machine learning, stressing the importance of finding a personal area of interest. She encourages aspiring researchers to explore fields where they can make meaningful contributions, leveraging available resources to enhance their learning.
"would never think that you can even apply machine learning - some of them are like matching you know their relations and you know that actually brings up an interesting point of computer science in ge..."
In a reflective discussion, Barzilay contemplates the meaning of life and research. She encourages individuals to pursue their own missions rather than conforming to external expectations, highlighting the importance of self-discovery and staying true to one's values.
"advice would you give the students interested in machine learning interested you've talked about detecting curing cancer drug design if they want to get into that field what what should they do get in..."
Barzilay shares her personal journey towards understanding her own motivations and values. She discusses the challenges of overcoming vanity and external pressures, emphasizing the role of reading and introspection in finding clarity and purpose in life.
"meaning of this thing of life of your life of research why do you think we descendant of great apes are here on this spinning ball you know I don't think that I have really a global answer you know ma..."